乙胆在人体内皮层功能和老龄化功能障碍中的中心作用在人类和小鼠中
Mala R Ananth1, John D Gardus2, Chuan Huang3
1National Institute of Neurological Disorders and Stroke, NIH, Bethesda, MD 20892, USA.
Cell reports
|February 1, 2025
概括
脑内皮层 (EC) 中的胆固醇系统衰退是人类和小鼠认知衰老的早期迹象. 这种损失会影响EC功能,并可能预测认知状态.
科学领域:
- 神经科学是一个神经科学.
- 衰老研究研究 衰老研究
- 认知科学 认知科学
背景情况:
- 脑内皮层 (EC) 的结构和功能变化是认知衰老的早期指标.
- 胆固醇系统在早期EC损伤和认知方面的作用尚未完全理解.
研究的目的:
- 为了研究胆固醇输入完整性和老龄化人类和小鼠的认知缺陷之间的关系.
- 为了确定是否损害胆能系统是早期内腔皮层损伤的主要驱动因素.
主要方法:
- 在老年人中使用了体内成像技术,包括正子发射断层扫描 (PET) 和磁共振成像 (MRI).
- 在野生型小鼠和基因易受阿尔茨海默氏症病理学影响的小鼠中采用高分辨率成像.
- 在小鼠中进行了机理学研究,以评估EC投射胆固醇神经元在行为中的作用.
主要成果:
- 脑内皮层 (EC) 输入胆固醇输入的损失是认知衰老的早期特征,在人类和小鼠中观察到.
- 在小鼠的机理学研究表明,EC-投射胆固醇神经元在EC相关行为中起着中心作用.
- 胆固醇EC的变化在各个物种中都保持不变,并且在衰老过程的早期出现.
结论:
- 脑内皮层 (EC) 的胆固醇输入受损是认知衰老的早期和保存特征.
- 在EC中失去胆固醇完整性可能是认知状态的早期预测因素.
- 针对欧洲共同体的胆固醇系统可能是缓解与年龄相关的认知衰退的潜在策略.
相关概念视频
Alzheimer's Disease: Overview
437
Alzheimer's Disease (AD) is a continually advancing neurodegenerative disorder, distinguished by escalating memory loss, cognitive dysfunction, and dementia. The disease unfolds in three stages: preclinical, mild cognitive impairment (MCI), and dementia. Its onset is insidious, and the progression gradual, with the cause not well explained by other disorders.
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
The clinical diagnosis of AD hinges on the presence of memory and other cognitive impairments. Biomarkers, such as changes in Aβ...
437
Role of Neurotransmitters in Memory
399
Neurotransmitters are integral to the brain's communication system, enabling neurons to transmit signals across synapses. This chemical exchange underpins various cognitive functions, including memory processes. The role of neurotransmitters in memory is multifaceted, influencing the encoding, consolidation, and retrieval of memories through their action on different neural circuits.
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
Glutamate and Synaptic Plasticity
Glutamate, the brain's main excitatory neurotransmitter, is...
399
Cognitive Enhancers: Cholinesterase Inhibitors and NMDA Receptor Antagonists
95
Cognitive enhancers, also known as "smart drugs," are substances used to enhance memory, mental alertness, and concentration. These can be natural or synthetic and improve cognition in conditions like Alzheimer's disease (AD) and other neurodegenerative diseases. Some common examples include caffeine, amphetamines, methylphenidate, modafinil, arecoline, donepezil, vortioxetine, and piracetam. These enhancers work on the principle of synaptic plasticity and altered circuit function.
95


